Gene · 6046
Papers3,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer. | Cell Death Dis | 2026 | 41872151 | PubTator, text mining | PubMed |
| The Future of Epigenetics: Emerging Technologies and Clinical Applications. | ACS Pharmacol Transl Sci | 2026 | 41852637 | PubTator, text mining | PubMed |
| WDHD1 promotes hepatocellular carcinoma progression by affecting the cell cycle and immune evasion. | Transl Oncol | 2026 | 41850053 | PubTator, text mining | PubMed |
| A Rare Case of Mediastinal NUT (Nuclear Protein in Testis) Carcinoma Presenting with Acute Respiratory Failure: A Case Report. | Int Med Case Rep J | 2026 | 41800272 | PubTator, text mining | PubMed |
| Interaction of coronavirus E protein with BRD2 plays important regulatory roles in viral replication and induction of pro-inflammatory response. | J Virol | 2026 | 41773861 | PubTator, text mining | PubMed |
| Two Sides of a Coin: Molecular, metabolic, and Phenotypic Convergence in Pediatric Undernutrition and Obesity. | Curr Obes Rep | 2026 | 41770447 | PubTator, text mining | PubMed |
| Quinoxaline Derivatives in Cancer Therapy: Insights into Mechanisms of Action and Therapeutic Applications. | Biomol Ther (Seoul) | 2026 | 41755772 | PubTator, text mining | PubMed |
| Early Transcriptomic Response of Human Iris Stromal Cells During Herpes Simplex Virus Entry Reveals Interplay Between Cell Glycocalyx and Viral Exploitation. | Int J Mol Sci | 2026 | 41751906 | PubTator, text mining | PubMed |
| Epigenetic Therapies for Inflammatory and Immune-Mediated Skin Diseases. | Biomedicines | 2026 | 41751272 | PubTator, text mining | PubMed |
| The Role of Cold-Inducible RNA-Binding Protein (CIRP) in Neurological Disorders. | Brain Sci | 2026 | 41750206 | PubTator, text mining | PubMed |
| Biological Functional Class Enrichment Analysis with R, an Annotated Tutorial for Bench Scientists. | Methods Protoc | 2026 | 41745221 | PubTator, text mining | PubMed |
| International guidelines on the diagnosis and treatment of NUT carcinoma. | Innovation (Camb) | 2026 | 41737331 | PubTator, text mining | PubMed |
| Viability of Dugesia dorotocephala Planaria with the Senolytic Drug ARV-825. | MicroPubl Biol | 2026 | 41728347 | PubTator, text mining | PubMed |
| RuPHOTACs Provide Photocontrol Over Protein Degradation with Optimized Properties for Biological Applications. | Res Sq | 2026 | 41727614 | PubTator, text mining | PubMed |
| Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets. | ACS Pharmacol Transl Sci | 2026 | 41710755 | PubTator, text mining | PubMed |
| Semi-rigid linkers improve the pharmacokinetic properties and therapeutic efficacy of BET PROTACs for cancer therapy. | Eur J Med Chem | 2026 | 41687266 | PubTator, text mining | PubMed |
| Unraveling AMPK and BET regulation of immune checkpoint biology: implications for personalized medicine. | bioRxiv | 2026 | 41659635 | PubTator, text mining | PubMed |
| CRISPR/Cas13a-Engineered RNA-Based Fluorogenic Biosensor for Label-Free Quantification of RNA in Colorectal Tissues. | Anal Chem | 2026 | 41640077 | PubTator, text mining | PubMed |
| Deciphering the regulatory landscape of enhancer RNAs in health and disease. | Signal Transduct Target Ther | 2026 | 41605892 | PubTator, text mining | PubMed |
| Intrinsic brain activity and multiscale mechanisms of auditory verbal hallucinations in schizophrenia: A systematic review and meta-analysis. | Neurosci Biobehav Rev | 2026 | 41605340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6046/papers?page=2